Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-27 @ 10:50 PM
Study NCT ID:
NCT04456634
Status:
COMPLETED
Last Update Posted:
2021-07-09
First Post:
2020-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine
Sponsor:
Medicines for Malaria Venture
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-18
First Submit QC Date:
None
Study First Post Date:
2020-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-04
Results First Submit QC Date:
None
Results First Post Date:
2021-07-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-18
Last Update Post Date:
2021-07-09
Last Update Post Date Type:
ACTUAL